Recurrent UTI in Women: Diagnosis and Management

Denise Zwahlen, MD
Jenna Ball, MD
Quinn Jackson, MD, MPH

American Family Physician. 2026;113(6):568-577.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Recurrent urinary tract infection (UTI) is defined as two or more UTIs within 6 months or three or more within 1 year. The annual recurrence rate of UTI in women is approximately 14% to 25%. Risk factors for recurrent UTI include antimicrobial exposures, more frequent sexual activity, use of spermicidal agents or diaphragms, peri- or postmenopausal status, personal hygiene practices, urinary stasis from incomplete bladder emptying, pelvic organ prolapse, and voiding dysfunction. When women present with recurrent UTI symptoms, urinalysis and urine culture should be obtained. Management guidelines recommend empiric treatment with a first-line antibiotic based on prior culture results, then changing the antibiotic if the new culture shows resistance, or waiting for culture results before selecting an antibiotic. Longer duration of therapy does not reduce the risk of recurrent UTI. Asymptomatic bacteriuria should not be treated, except in patients who are pregnant or undergoing invasive urologic procedures. Prevention of recurrent UTI begins with behavioral modification and hygienic practices. The next step is prescription of antibiotic prophylaxis with shared decision-making. Nonantibiotic methods are also used to prevent recurrent UTI, and evidence of their effectiveness varies. These methods include use of cranberry products, Lactobacillus probiotics, vaginal estrogen, methenamine supplements.

DENISE ZWAHLEN, MD, is an associate professor in the Department of Family Medicine and Community Health and assistant dean for student affairs at the University of Kansas School of Medicine in Kansas City.

JENNA BALL, MD, is an assistant professor in the Department of Family Medicine and Community Health at the University of Kansas School of Medicine in Kansas City.

QUINN JACKSON, MD, MPH, FAAFP, is an assistant professor in the Department of Family and Community Health at the University of Kansas School of Medicine in Kansas City.

Address correspondence to Denise Zwahlen, MD, at dzwahlen@kumc.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Advani SD, Thaden JT, Perez R, et al. State-of-the-art review: recurrent uncomplicated urinary tract infections in women. Clin Infect Dis. 2025;80(3):e31-e42.
  2. 2.Anger J, Lee U, Ackerman AL, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202(2):282-289.
  3. 3.Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366(11):1028-1037.
  4. 4.Neugent ML, Hulyalkar NV, Nguyen VH, et al. Advances in understanding the human urinary microbiome and its potential role in urinary tract infection. MBio. 2020;11(2):e00218-e00220.
  5. 5.Brubaker L, Wolfe AJ. The female urinary microbiota, urinary health and common urinary disorders. Ann Transl Med. 2017;5(2):34.
  6. 6.Chai TC, Wolfe AJ, Brubaker L. The urinary microbiome: improving diagnostics and management of urinary tract infections in adult females. Infect Dis Clin North Am. 2024;38(2):241-253.
  7. 7.Liao W, Jiang Y, Jhang J. Pathophysiology and potential treatment modalities in women with recurrent urinary tract infection. Tzu Chi Med J. 2025;37(2):117-124.
  8. 8.American Urological Association. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline (2025). Accessed April 3, 2026. https://www.auanet.org/guidelines-and-quality/guidelines/recurrent-uti
  9. 9.Gupta K, Trautner BW. Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ. 2013;346:f3140.
  10. 10.Aggarwal N, Leslie SW. Recurrent urinary tract infections. StatPearls. Updated January 20, 2025. Accessed January 30, 2026. https://www.ncbi.nlm.nih.gov/books/NBK557479/
  11. 11.Stamm WE, Raz R. Factors contributing to susceptibility of post-menopausal women to recurrent urinary tract infections. Clin Infect Dis. 1999;28(4):723-725.
  12. 12.Ackerson BK, Tartof SY, Chen LH, et al. Risk factors for recurrent urinary tract infections among women in a large integrated health care organization in the United States. J Infect Dis. 2024;230(5):e1101-e1111.
  13. 13.Clemens JQ, Erickson DR, Varela NP, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34-42.
  14. 14.Hoffman A, Dolezal KA, Powell R. Dysuria: evaluation and differential diagnosis in adults. Am Fam Physician. 2025;111(1):37-46.
  15. 15.Fletcher SG, Zimmern PE. Differential diagnosis of chronic pelvic pain in women: the urologist's approach. Nat Rev Urol. 2009;6(10):557-562.
  16. 16.Bafna P, Deepanjali S, Mandal J, et al. Reevaluating the true diagnostic accuracy of dipstick tests to diagnose urinary tract infection using Bayesian latent class analysis. PLoS One. 2020;15(12):e0244870.
  17. 17.Hitzeman N, Greer D, Carpio E. Office-based urinalysis: a comprehensive review. Am Fam Physician. 2022;106(1):27-35B.
  18. 18.Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. Published online March 5, 2024. Accessed January 20, 2026. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciae104/7619499
  19. 19.Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):e83-e110.
  20. 20.Ashmore S, Shi J, Samsel T, et al. Rate of urine culture contamination with different methods of urine specimen collection. Int Urogynecol J. 2025;36(5):1029-1035.
  21. 21.Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5(5):316-322.
  22. 22.Gupta K, Hooton TM, Naber KG, et al.; Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120.
  23. 23.Ackerman AL, Bradley M, D'Anci KE, et al. Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline (2025). J Urol. 2026;215(1):3-12.
  24. 24.Xu R, Deebel N, Casals R, et al. A new gold rush: a review of current and developing diagnostic tools for urinary tract infections. Diagnostics (Basel). 2021;11(3):479.
  25. 25.Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med. 2001;135(1):9-16.
  26. 26.Arnold JJ, Hehn LE, Klein DA. Common questions about recurrent urinary tract infections in women. Am Fam Physician. 2016;93(7):560-569.
  27. 27.Schmiemann G, Kranz J, Mandraka F, et al. The diagnosis, treatment, and prevention of recurrent urinary tract infection. Dtsch Arztebl Int. 2024;121(11):373-382.
  28. 28.Valentine-King MA, Trautner BW, Zoorob RJ, et al. Predicting antibiotic susceptibility among patients with recurrent urinary tract infection using a prior culture. J Urol. 2024;211(1):144-152.
  29. 29.Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines group consensus statement. JAMA Netw Open. 2024;7(11):e2444495.
  30. 30.Peck J, Shepherd JP. Recurrent urinary tract infections: diagnosis, treatment, and prevention. Obstet Gynecol Clin North Am. 2021;48(3):501-513.
  31. 31.Milo G, Katchman E, Paul M, et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev. 2005(2):CD004682.
  32. 32.Katchman EA, Milo G, Paul M, et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med. 2005;118(11):1196-1207.
  33. 33.Lutters M, Vogt-Ferrier NB. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database Syst Rev. 2008(3):CD001535.
  34. 34.Suskind AM, Saigal CS, Hanley JM, et al.; Urologic Diseases of America Project. Incidence and management of uncomplicated recurrent urinary tract infections in a national sample of women in the United States. Urology. 2016;90:50-55.
  35. 35.Valentine-King MA, Trautner BW, Zoorob RJ, et al. Analysis of recurrent urinary tract infection management in women seen in outpatient settings reveals opportunities for antibiotic stewardship interventions. Antimicrob Steward Healthc Epidemiol. 2022;2(1):e8.
  36. 36.Shinnick J, Josephs I, Suskin JA, et al. Antibiotic duration and UTI outcomes in recurrent UTI patients. Urogynecology (Phila). 2025;31(1):34-42.
  37. 37.Cai T, Nesi G, Mazzoli S, et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis. 2015;61(11):1655-1661.
  38. 38.Stall NM, Kandel C, Reppas-Rindlisbacher C, et al. Antibiotics for delirium in older adults with pyuria or bacteriuria: a systematic review. J Am Geriatr Soc. 2024;72(8):2566-2578.
  39. 39.Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: a prospective cohort study. Arch Gerontol Geriatr. 2017;72:127-134.
  40. 40.Potts L, Cross S, MacLennan WJ, et al. A double-blind comparative study of norfloxacin versus placebo in hospitalised elderly patients with asymptomatic bacteriuria. Arch Gerontol Geriatr. 1996;23(2):153-161.
  41. 41.Anger JT, Bixler BR, Holmes RS, et al. Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2022;208(3):536-541.
  42. 42.Kostelnik SB, Davy KP, Hedrick VE, et al. The validity of urine color as a hydration biomarker within the general adult population and athletes: a systematic review. J Am Coll Nutr. 2021;40(2):172-179.
  43. 43.Mahdizade Ari M, Dashtbin S, Ghasemi F, et al. Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review. Front Cell Infect Microbiol. 2023;13:1148603.
  44. 44.Wijma RA, Huttner A, Koch BCP, et al. Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. J Antimicrob Chemother. 2018;73(11):2916-2926.
  45. 45.Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Microbiol. 2022;12:963868.
  46. 46.Sadahira T, Wada K, Araki M, et al. Efficacy of Lactobacillus vaginal suppositories for the prevention of recurrent cystitis: a phase II clinical trial. Int J Urol. 2021;28(10):1026-1031.
  47. 47.Shoureshi PS, Niino C, Eilber KS. Can vaginal lactobacillus suppositories help reduce urinary tract infections?. Int Urogynecol J. 2023;34(11):2713-2718.
  48. 48.Huttner A, Kowalczyk A, Turjeman A, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial. JAMA. 2018;319(17):1781-1789.
  49. 49.Harding C, Chadwick T, Homer T, et al. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health Technol Assess. 2022;26(23):1-172.
  50. 50.Doiron RC, Cotechini T, Nickel JC. It's time to embrace vaccination as we enter the postantibiotic era of recurrent urinary tract infection management. J Urol. 2024;211(6):797-799.
  51. 51.Qin X, Coyle ME, Yang L, et al. Acupuncture for recurrent urinary tract infection in women: a systematic review and meta-analysis. BJOG. 2020;127(12):1459-1468.
  52. 52.Hayward G, Mort S, Hay AD, et al. d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern Med. 2024;184(6):619-628.
  53. 53.Murali Krishna M, Joseph M, Pereira V. D-Mannose for prevention of recurrent urinary tract infection in adult women: an updated systematic review and meta-analysis of randomized controlled trials.. J Infect Prev. 2025 : 17571774251394869.
  54. 54.Hiprex (methenamine hippurate tablets USP) [package insert]. Validus Pharmaceuticals LLC; 2017. Accessed April 1, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017681s018lbl.pdf
  55. 55.Monane M, Gurwitz JH, Lipsitz LA, et al. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995;43(6):618-622.
  56. 56.Hanlon JT, Perera S, Drinka PJ, et al. The IOU consensus recommendations for empirical therapy of cystitis in nursing home residents. J Am Geriatr Soc. 2019;67(3):539-545.
  57. 57.Kelly CR, Fischer M, Allegretti JR, et al. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021;116(6):1124-1147.
  58. 58.Urinary tract infections in pregnant individuals. Obstet Gynecol. 2023;142(2):435-445.
  59. 59.Glaser AP, Schaeffer AJ. Urinary tract infection and bacteriuria in pregnancy. Urol Clin North Am. 2015;42(4):547-560.
  60. 60.Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335(7):468-474.
  61. 61.Fihn SD, Boyko EJ, Normand EH, et al. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Am J Epidemiol. 1996;144(5):512-520.
  62. 62.Diebold R, Schopf B, Stammer H, et al. Vaginal treatment with lactic acid gel delays relapses in recurrent urinary tract infections: results from an open, multicentre observational study. Arch Gynecol Obstet. 2021;304(2):409-417.
  63. 63.Phexxi (lactic acid, citric acid monohydrate, and potassium bitartrate) vaginal gel [package insert]. Evofem Inc.; 2023. Accessed January 30, 2026. https://22077562.fs1.hubspotusercontent-na1.net/hubfs/22077562/PhexxiProductInformation.pdf
  64. 64.Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgender Health. 2022;23:S1-S259.
  65. 65.Gilbert D, Gautam A, Tabernacki T, et al. Rates of urinary tract infection in transgender women postvaginoplasty vs cisgender women: a retrospective cohort study in a large US health network. Urology. 2024;188:150-155.
  66. 66.Ding C, Khondker A, Goldenberg MG, et al. Urinary complications after penile inversion vaginoplasty in transgender women systematic review and meta-analysis. Can Urol Assoc J. 2023;17(4):121-128.
  67. 67.Kodner CM, Thomas Gupton EK. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician. 2010;82(6):638-643.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.